Agenus reports $4.6 million in pre-commercial revenue for Q1 2026

May 11, 2026 8:45 AM

Agenus Inc. (NASDAQ: AGEN) reported first quarter 2026 financial results, showing $4.6 million in pre-commercial product revenue from its botensilimab ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found